CoChat

Positron emission tomography imaging of the 18-kDa translocator protein (TSPO) with [18F]FEMPA in Alzheimer’s disease patients and control subjects

Open access
Varrone, Andrea, Oikonen, Vesa, Forsberg, Anton, Joutsa, Juho, Takano, Akihiro, Solin, Olof, Haaparanta-Solin, Merja, Nag, Sangram, Nakao, Ryuji, Al-Tawil, Nabil, Wells, Lisa A., Rabiner, Eugenii A., Valencia, Ray, Schultze-Mosgau, Marcus, Thiele, Andrea, Vollmer, Sonja, Dyrks, Thomas, Lehmann, Lutz, Heinrich, Tobias, Hoffmann, Anja, Nordberg, Agneta, Halldin, Christer, Rinne, Juha O. · 2015 · European Journal of Nuclear Medicine and Molecular Imaging
Cited by 79

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

PurposeImaging of the 18-kDa translocator protein (TSPO) is a potential tool for examining microglial activation and neuroinflammation in early Alzheimer’s disease (AD). [18F]FEMPA is a novel high-affinity second-generation TSPO radioligand that has displayed suitable pharmacokinetic properties in preclinical studies. The aims of this study were to quantify the binding of [18F]FEMPA to TSPO in AD patients and controls and to investigate whether higher [18F]FEMPA binding in AD patients than in controls could be detected in vivo.MethodsTen AD patients (five men, five women; age 66.9 ± 7.3 years; MMSE score 25.5 ± 2.5) and seven controls (three men, four women; age 63.7 ± 7.2 years, MMSE score 29.3 ± 1.0) were studied using [18F]FEMPA at Turku (13 subjects) and at Karolinska Institutet (4 subjects). The in vitro binding affinity for TSPO was assessed using PBR28 in a competition assay with [3H]PK11195 in seven controls and eight AD patients. Cortical and subcortical regions of interest were examined. Quantification was performed using a two-tissue compartment model (2TCM) and Logan graphical analysis (GA). The outcome measure was the total distribution volume (VT). Repeated measures analysis of variance was used to assess the effect of group and TSPO binding status on VT.ResultsFive AD patients and four controls were high-affinity binders (HABs). Three AD patients and three controls were mixed-affinity binders. VT estimated with Logan GA was significantly correlated with VT estimated with the 2TCM in both controls (r = 0.97) and AD patients (r = 0.98) and was selected for the final analysis. Significantly higher VT was found in the medial temporal cortex in AD patients than in controls (p = 0.044) if the TSPO binding status was entered as a covariate. If only HABs were included, significantly higher VT was found in the medial and lateral temporal cortex, posterior cingulate, caudate, putamen, thalamus and cerebellum in AD patients than in controls (p < 0.05).Conclusion[18F]FEMPA seems to be a suitable radioligand for detecting increased TSPO binding in AD patients if their binding status is taken into account.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00259-014-2955-8

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

Metadata

Authors
Varrone, A., Oikonen, V., Forsberg, A., Joutsa, J., Takano, A., Solin, O., Haaparanta-Solin, M., Nag, S., Nakao, R., Al-Tawil, N., Wells, L. A., Rabiner, E. A., Valencia, R., Schultze-Mosgau, M., Thiele, A., Vollmer, S., Dyrks, T., Lehmann, L., Heinrich, T., Hoffmann, A., Nordberg, A., Halldin, C., & Rinne, J. O.
Venue
European Journal of Nuclear Medicine and Molecular Imaging
Published
2014-11-21
Volume
42
Issue
3
Pages
438-446
ISSN
  • 1619-7070 (ISSN-L)
  • 1619-7089
OpenAlex
W2170978964
Cited by
79
References
9
FWCI
4.66
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.